SecBot SecBot
SECBOTREPLAY Home › Report › VRTX

VRTX · Three senior executives at Vertex Pharmaceuticals, including the CEO…

VERTEX PHARMACEUTICALS INC / MA · CLUSTER filed Feb 24, 2026 at 19:00 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Feb 24, 2026 at 19:00 ET

Three senior executives at Vertex Pharmaceuticals, including the CEO and two EVPs, sold shares in a coordinated 7-day window, generating over $1.75 million in proceeds. All transactions were open-market sales at prevailing prices, with no grants, awards, or tax-related dispositions involved.

  • CEO Reshma Kewalramani sold 400 shares for $191,900 in an open-market transaction.
  • EVP Carmen Bozic sold 2,329 shares for $1.12M, the largest individual sale in the cluster.
  • EVP Joy Liu sold 892 shares for $442,396, completing the cluster of C-suite dispositions.
  • Total value of open-market sales: $1.753M across three insiders, all within seven days.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access